154 related articles for article (PubMed ID: 33954928)
21. Frequent PIK3CA activating mutations in nipple adenomas.
Liau JY; Lee YH; Tsai JH; Yuan CT; Chu CY; Hong JB; Sheen YS
Histopathology; 2017 Jan; 70(2):195-202. PubMed ID: 27441415
[TBL] [Abstract][Full Text] [Related]
22. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutations in incident sporadic colorectal adenomas.
Barry EL; Baron JA; Grau MV; Wallace K; Haile RW
Cancer; 2006 Mar; 106(5):1036-40. PubMed ID: 16456810
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.
Kopreski MS; Benko FA; Borys DJ; Khan A; McGarrity TJ; Gocke CD
J Natl Cancer Inst; 2000 Jun; 92(11):918-23. PubMed ID: 10841827
[TBL] [Abstract][Full Text] [Related]
26. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
27. K-ras gene mutations in adenomas and carcinomas of the colon.
Boughdady IS; Kinsella AR; Haboubi NY; Schofield PF
Surg Oncol; 1992 Aug; 1(4):275-82. PubMed ID: 1341261
[TBL] [Abstract][Full Text] [Related]
28. [K-ras gene mutations in adenomas from familial adenomatous polyposis].
Ohki S; Onda M; Nomizu T; Tsuchiya A; Ami H; Fukushima T; Takita K; Kanazawa M; Watanabe F; Andoh Y; Yoshida T; Abe R
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():154-8. PubMed ID: 8678560
[TBL] [Abstract][Full Text] [Related]
29. High frequency of K-ras mutations in sporadic colorectal adenomas.
McLellan EA; Owen RA; Stepniewska KA; Sheffield JP; Lemoine NR
Gut; 1993 Mar; 34(3):392-6. PubMed ID: 8472989
[TBL] [Abstract][Full Text] [Related]
30. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
31. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.
Ohnishi T; Tomita N; Monden T; Ohue M; Yana I; Takami K; Yamamoto H; Yagyu T; Kikkawa N; Shimano T; Monden M
Br J Cancer; 1997; 75(3):341-7. PubMed ID: 9020477
[TBL] [Abstract][Full Text] [Related]
32. Case report: recurrent pituitary adenoma has increased load of somatic variants.
Peculis R; Balcere I; Radovica-Spalvina I; Konrade I; Caune O; Megnis K; Rovite V; Stukens J; Nazarovs J; Breiksa A; Kiecis A; Silamikelis I; Pirags V; Klovins J
BMC Endocr Disord; 2020 Jan; 20(1):17. PubMed ID: 31996211
[TBL] [Abstract][Full Text] [Related]
33. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
34. K-ras mutations and HLA-DR expression in large bowel adenomas.
Norheim Andersen S; Breivik J; Løvig T; Meling GI; Gaudernack G; Clausen OP; Schjölberg A; Fausa O; Langmark F; Lund E; Rognum TO
Br J Cancer; 1996 Jul; 74(1):99-108. PubMed ID: 8679466
[TBL] [Abstract][Full Text] [Related]
35. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
37. B-RAF mutations are a rare event in pituitary adenomas.
De Martino I; Fedele M; Palmieri D; Visone R; Cappabianca P; Wierinckx A; Trouillas J; Fusco A
J Endocrinol Invest; 2007 Jan; 30(1):RC1-3. PubMed ID: 17318013
[TBL] [Abstract][Full Text] [Related]
38. p53 expression and K-ras mutation in colorectal adenomas.
Scott N; Bell SM; Sagar P; Blair GE; Dixon MF; Quirke P
Gut; 1993 May; 34(5):621-4. PubMed ID: 8504962
[TBL] [Abstract][Full Text] [Related]
39. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
[TBL] [Abstract][Full Text] [Related]
40. Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer.
Moati E; Blons H; Taly V; Garlan F; Wang-Renault SF; Pietrasz D; Didelot A; Garrigou S; Saint A; Pernot S; Taieb J; Laurent-Puig P; Zaanan A
Int J Cancer; 2020 Aug; 147(4):1185-1189. PubMed ID: 31472013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
